Evidence map›Paper›PMID 28186968›Full record

ArticleOncotarget2017

XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p.

Qiang Wu, Hong Yan, Si-Qi Tao, Xiao-Nan Wang, Lang Mou, Ping Chen, Xing-Wang Cheng, Wen-Yong Wu, Zheng-Sheng Wu

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Endogenous miRNA Sponges.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. AberrantFEBS open bio · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Qiang WuDepartment of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Hong YanDepartment of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Si-Qi TaoDepartment of Pathology, Anhui Medical University, Hefei, Anhui, China.
Xiao-Nan WangLaboratory of Pathogenic Microbiology and Immunology, Anhui Medical University, Hefei, Anhui, China.
Lang MouDepartment of Pathology, Anhui Medical University, Hefei, Anhui, China.
Ping ChenDepartment of Pathology, Anhui Medical University, Hefei, Anhui, China.
Xing-Wang ChengDepartment of Emergency, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
Wen-Yong WuDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Zheng-Sheng WuDepartment of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Anhui Medical University · CNSecond Hospital of Anhui Medical University · CNAnhui Provincial Hospital · CNFirst Affiliated Hospital of Anhui Medical University · CNFirst Affiliated Hospital of Bengbu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The non-coding 3'-untranslated region (UTR) of genes play an important role in the regulation of microRNA (miRNA) functions, since it can bind and inactivate multiple miRNAs. Herein, we report that ectopic expression of XIAP 3'UTR increased human breast cancer cells proliferation, colony formation, migration, invasion and xenograft tumor growth and suppressed tumor cell death. To investigate this process, we further correlated the genome-wide transcriptional profiling with the gene expression alterations after transfecting XIAP 3'UTR in MCF-7 cells. We identified a robust, genome-wide mechanism of cell migration, motility and epithelial to mesenchymal transition by which mediated by a previously described cellular component movement factor FSCN1. Expression of XIAP and FSCN1 were up-regulated synergistically after transfecting XIAP 3'UTR in vitro and in vivo. Interactions between XIAP and FSCN1 appear to be a key determinant of these processes. Co-transfection with Dicer siRNA reversed the XIAP 3'UTR-mediated oncogenicity, suggesting the miRNAs might be involved in that process. Furthermore, we demonstrated that one miRNA, miR-29a-5p, can bind to both the XIAP and FSCN1 3'UTRs and play an important role in that interactions. We showed that the 3'UTR of XIAP was able to antagonize miR-29a-5p, and resulted in the increased translation of XIAP and FSCN1. Thus, our findings reveal important new insights into how XIAP 3'UTR works, suggesting that the non-coding XIAP 3'UTR serves as a competitor for miRNA binding and subsequently inactivates miRNA functions, by which XIAP 3'UTR frees the target mRNAs from being repressed.

Indexed as

3' Untranslated RegionsAnimalsBreast NeoplasmsCarrier ProteinsCell Line, TumorCell ProliferationFemaleHeterograftsHumansMCF-7 CellsMiceMice, Inbred BALB CMice, NudeMicrofilament ProteinsMicroRNAsRNA, Small Interfering3' Untranslated RegionsCarrier ProteinsFSCN1 protein, humanMicrofilament ProteinsMicroRNAsMIRN29a microRNA, humanRNA, Small InterferingXIAP protein, humanX-Linked Inhibitor of Apoptosis Protein3'UTRbreast cancermiRNAXIAP

Identifiers

PMID28186968
PMCPMC5370001
OpenAlexW2586159898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.